Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.52 |
| ▸ | NPY4R | P50391 | 4/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.51 |
| ▸ | NPY1R | P25929 | 3/20 | 0.51 |
| ▸ | NPY2R | P49146 | 1/20 | 0.51 |
| ▸ | NMT2 | O60551 | 1/20 | 0.47 |
| ▸ | NMT1 | P30419 | 1/20 | 0.47 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | FNTA | P49354 | 2/20 | 0.46 |
| ▸ | FNTB | P49356 | 2/20 | 0.46 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.44 |
| ▸ | GLP1R | P43220 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19499060 | 0.88 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL4277325 | 0.88 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL11102827 | 0.88 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL2341993 | 0.88 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL19499048 | 0.88 | NOD1 (0.53) | NOD1NPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL4278821 | 0.88 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL2341081 | 0.88 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL19499049 | 0.88 | NOD1 (0.53) | NOD1NPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL2341089 | 0.88 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL2340732 | 0.88 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6974582-B2 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2005-12-13 | — | — | US | claimed |
| US-10786437-B2 | Composition for cosmetics and cosmetics comprising same | AJINOMOTO CO., INC (JP) | 2020-09-29 | — | — | US | disclosed |
| US-10736826-B2 | Cream-like composition | AJINOMOTO CO., INC. (JP) | 2020-08-11 | — | — | US | disclosed |
| US-20190133897-A1 | CREAM-LIKE COMPOSITION | AJINOMOTO CO., INC. (JP) | 2019-05-09 | — | — | US | disclosed |
| EP-1264590-B1 | Cosmetic composition | AJINOMOTO KK (JP) | 2011-08-24 | — | — | EP | disclosed |
| US-7608250-B2 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2009-10-27 | — | — | US | disclosed |
| US-20060029626-A1 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2006-02-09 | — | — | US | disclosed |
| US-6974582-B2 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2005-12-13 | — | — | US | disclosed |
| US-20030165448-A1 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2003-09-04 | — | — | US | disclosed |
| US-20030124155-A1 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2003-07-03 | — | — | US | disclosed |
| US-20030124156-A1 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2003-07-03 | — | — | US | disclosed |
| EP-1264591-A2 | Cosmetic composition | Ajinomoto Co., Inc. (JP) | 2002-12-11 | — | — | EP | disclosed |
| EP-1264590-A2 | Cosmetic composition | Ajinomoto Co., Inc. (JP) | 2002-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030165448-A1 | Cosmetic composition | CUTA, ARGLU1, ASS1 | NOD1 4534/4885NPY4R 3013/4885NPY5R 1491/4885 |
| US-20060029626-A1 | Cosmetic composition | CUTA, NGLY1, ARG1 | NOD1 4286/4885NPY4R 2345/4885NPY5R 1115/4885 |
| US-20030124155-A1 | Cosmetic composition | CUTA, ASS1, SMS | NOD1 4831/4885NPY4R 4395/4885NPY5R 2249/4885 |
| US-20030124156-A1 | Cosmetic composition | CUTA, PARG, PARN | NOD1 4865/4885NPY4R 4056/4885NPY5R 2135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.